Pallas Capital Advisors LLC Has $437,000 Stock Position in Omega Healthcare Investors, Inc. $OHI

Pallas Capital Advisors LLC increased its stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 59.0% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 11,915 shares of the real estate investment trust’s stock after purchasing an additional 4,420 shares during the quarter. Pallas Capital Advisors LLC’s holdings in Omega Healthcare Investors were worth $437,000 as of its most recent filing with the SEC.

Several other institutional investors have also made changes to their positions in OHI. Triumph Capital Management acquired a new stake in Omega Healthcare Investors in the second quarter valued at approximately $321,000. MassMutual Private Wealth & Trust FSB increased its position in Omega Healthcare Investors by 562.3% during the second quarter. MassMutual Private Wealth & Trust FSB now owns 1,828 shares of the real estate investment trust’s stock worth $67,000 after acquiring an additional 1,552 shares during the period. RF&L Wealth Management LLC boosted its stake in Omega Healthcare Investors by 3.8% during the second quarter. RF&L Wealth Management LLC now owns 30,195 shares of the real estate investment trust’s stock worth $1,107,000 after buying an additional 1,104 shares in the last quarter. Teamwork Financial Advisors LLC boosted its stake in Omega Healthcare Investors by 6.9% during the second quarter. Teamwork Financial Advisors LLC now owns 19,738 shares of the real estate investment trust’s stock worth $723,000 after buying an additional 1,273 shares in the last quarter. Finally, Greenfield Savings Bank boosted its stake in shares of Omega Healthcare Investors by 11.1% in the 2nd quarter. Greenfield Savings Bank now owns 15,622 shares of the real estate investment trust’s stock valued at $573,000 after purchasing an additional 1,557 shares in the last quarter. 65.25% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on OHI. Raymond James Financial reiterated an “outperform” rating on shares of Omega Healthcare Investors in a research report on Tuesday, September 2nd. Royal Bank Of Canada upped their price target on Omega Healthcare Investors from $39.00 to $41.00 and gave the company a “sector perform” rating in a research note on Thursday, August 7th. Wells Fargo & Company upped their price target on Omega Healthcare Investors from $41.00 to $44.00 and gave the company an “overweight” rating in a research note on Wednesday, August 27th. Scotiabank increased their target price on Omega Healthcare Investors from $39.00 to $42.00 and gave the stock a “sector perform” rating in a research note on Thursday, August 28th. Finally, Mizuho increased their target price on Omega Healthcare Investors from $37.00 to $40.00 and gave the stock a “neutral” rating in a research note on Thursday, September 11th. Five equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat, Omega Healthcare Investors presently has an average rating of “Moderate Buy” and an average price target of $43.75.

Omega Healthcare Investors Stock Performance

Omega Healthcare Investors stock opened at $41.45 on Friday. Omega Healthcare Investors, Inc. has a 12-month low of $35.04 and a 12-month high of $44.42. The company has a quick ratio of 7.10, a current ratio of 7.10 and a debt-to-equity ratio of 0.96. The business’s 50-day moving average price is $40.78 and its two-hundred day moving average price is $38.41. The stock has a market cap of $12.23 billion, a PE ratio of 25.58, a P/E/G ratio of 2.17 and a beta of 0.71.

Omega Healthcare Investors (NYSE:OHI) last announced its quarterly earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 EPS for the quarter, beating analysts’ consensus estimates of $0.45 by $0.32. The firm had revenue of $235.60 million for the quarter, compared to analyst estimates of $248.49 million. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%.The business’s revenue for the quarter was up 11.8% on a year-over-year basis. During the same period last year, the firm posted $0.71 earnings per share. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. As a group, analysts expect that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current fiscal year.

Omega Healthcare Investors Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Monday, August 4th were given a $0.67 dividend. This represents a $2.68 dividend on an annualized basis and a yield of 6.5%. The ex-dividend date of this dividend was Monday, August 4th. Omega Healthcare Investors’s dividend payout ratio is presently 165.43%.

Insider Activity

In other news, Director Lisa Egbuonu-Davis sold 2,500 shares of the firm’s stock in a transaction on Friday, August 8th. The stock was sold at an average price of $40.16, for a total transaction of $100,400.00. Following the completion of the sale, the director directly owned 18,654 shares of the company’s stock, valued at $749,144.64. This trade represents a 11.82% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 1.50% of the stock is currently owned by corporate insiders.

Omega Healthcare Investors Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.